Come acquistare questo libro

Ordina questo libro su Amazon!

Ordina questo libro su IBS!

Per avere ulteriori informazioni puoi scriverci al seguente indirizzo: hygeiapress@hygeiapress.com.

Descrizione

“Autismo. Nuove strategie di diagnosi e cura” a cura di Salvatore Vendemmia e Maria Vendemmia

ISBN 9788898636204, collana: Saggi, 184 pagine, € 24,95, prima edizione: febbraio 2019

Curatori: Salvatore Vendemmia, Maria Vendemmia. Autori: Provvidenza Maria Abruzzo, Roberto Antonucci, Federico Balzola, Luigi Barberini, Alessandra Bolotta, Ernesto Burgio, Giuseppe Caramia, Carlo Cioffi, Speranza Cioffi, Paolo Curatolo, Mario Diurni, Vassilios Fanos, Claudia Fattuoni, Laura Formenti, Ruggiero Francavilla, Maria Laura Galli, Alessandro Ghezzo, Andrea Manzotti, Marina Marini, Luigi Mazzone, Lucio Moderato, Michele Mussap, Antonio Noto, Cristina Panisi, Chiara Pezzana, Roberta Pintus, Dario Siniscalco, Martina Siracusano, Nadia Vacca, David Vagni, Maria Vendemmia, Nicola Vendemmia, Salvatore Vendemmia

Perché un nuovo libro sull’autismo? Basterebbe rispondere con i dati a disposizione: negli Stati Uniti è autistico 1 bambino su 59. In Italia si stima che vi siano 300.000-400.000 persone con un disturbo dello spettro autistico, tra bambini, adolescenti, adulti.

Questo libro nasce dall’esigenza di costruire un ponte tra la ricerca più avanzata e la pratica quotidiana. Troverete molte risposte a numerose domande sui disturbi dello spettro autistico.

Un gruppo interdisciplinare di esperti vi accompagnerà a scoprire le ultime novità in aree inesplorate, dall’epigenetica dei primi mille giorni di vita, al rapporto tra cervello e intestino (il nostro secondo cervello), dalla metabolomica alla microbiomica, dall’importanza strategica dell’ambiente fino agli strumenti legislativi.

Da queste considerazioni nasce la proposta del GLIA (Gruppo di Lavoro Interdisciplinare per l’Autismo), con l’obiettivo di intercettare le esigenze emergenti. Un percorso da offrire ai bambini e alle loro famiglie per vedere con occhi nuovi le problematiche di sempre, costruire un nuovo modello di gestione e dare risposte personalizzate ai singoli individui. Una grande sfida, un passo avanti per rendere possibile il futuro.

Indice

Introduzione
Salvatore Vendemmia, Maria Vendemmia

1. Il GLIA (Gruppo di Lavoro Interdisciplinare per l’Autismo) e i disturbi dello spettro autistico: coerenza tra modello patogenetico, ricerca e assistenza
Cristina Panisi, Ernesto Burgio, Chiara Pezzana, Vassilios Fanos
Evoluzione del modello patogenetico • Modello DOHaD per il disturbo dello spettro autistico: implicazioni per la ricerca e l’assistenza • Il GLIA (Gruppo di Lavoro Interdisciplinare per l’Autismo)

2. Sguardo e comportamento… dei professionisti dell’autismo
Cristina Panisi
Necessità di una diagnosi precoce e di un intervento psicoeducativo tempestivo • Il modello in chiave epigenetica • Adeguamento del modello di assistenza clinica • Condivisione di un modello culturale tra clinici e ricercatori

3. Neurobiologia e scienze cognitive nei disturbi dello spettro autistico. Cause diverse per uno stesso comportamento
David Vagni
Le teorie neurocognitive • Gli interventi psicosociali e comportamentali • Meltdown • Ansia e comportamenti problema • Conclusioni

4. Suoni, luci e carezze per una vita che inizia presto e in salita
Roberto Antonucci, Nadia Vacca
L’influenza dell’ambiente sull’outcome neuroevolutivo del prematuro • Il Neonatal Integrative Developmental Care Model (IDC) • Conclusioni

5. Disturbi dello Spettro Autistico: dalla genetica all’epigenetica
Ernesto Burgio
Dati epidemiologici: aumento reale o semplice incremento di diagnosi? La pandemia silenziosa • Epigenetica versus genetica • Cervello versus reti neurali (connettoma) • Strategie sanitarie da adottare nei prossimi anni

6. Un corpo sotto il comportamento: importanza di una prospettiva sistemica
Cristina Panisi
Disturbo dello spettro autistico come parte di un disturbo sistemico • Modello patogenetico plausibile per epidemiologia e fenotipo di ASD • Meccanismi patogenetici e fattori di rischio • Sistema immunitario e autismo • Gut-immuno-brain axis • Conclusioni

7. Autismo e metabolomica
Antonio Noto, Michele Mussap, Maria Vendemmia, Vassilios Fanos
L’enigma “autismo” • Il ruolo determinante del microbiota intestinale • Cosa può rivelare la metabolomica

8. Analisi metabolomica urinaria di soggetti affetti da disturbo dello spettro autistico
Antonio Noto, Claudia Fattuoni, Michele Mussap, Luigi Barberini, Martina Siracusano, Luigi Mazzone, Ruggiero Francavilla, Paolo Curatolo, Vassilios Fanos
Materiali e metodi dello studio • Risultati • Un’impronta metabolica urinaria unica

9. L’autismo e il microbiota intestinale
Vassilios Fanos, Maria Vendemmia
Microbiota e fisiopatologia intestinale • Gli psicobiotici • L’autismo e la disbiosi • I Clostridia e l’autismo • Trapianto di microbiota fecale nei bambini autistici

10. Il ginepraio dei disordini dello spettro autistico (ASD): metabolomica, microbiomica, paracetamolo
Vassilios Fanos, Antonio Noto, Roberta Pintus, Michele Mussap
Un ginepraio di interazioni • Programming fetale e neonatale • La metabolomica • Il ruolo dell’acido propanoico (o propionico) • Il ruolo dei farmaci

11. Stress ossidativo e autismo: aspetti pato­genetici e razionale per possibili strategie di intervento
Marina Marini, Provvidenza Maria Abruzzo, Alessandra Bolotta, Alessandro Ghezzo
Lo stress ossidativo • L’infiammazione • Il ruolo dei lipidi • Il ruolo dell’intestino e del microbiota • Conclusione e possibili strategie

12. Manifestazioni gastrointestinali nei pazienti con autismo
Federico Balzola
Manifestazioni gastrointestinali • Case reports • Conclusione

13. Il dolore nelle persone con autismo: quando sospettarlo e come valutarlo
Maria Laura Galli
La criticità del diagnostic overshadowing • La condizione di dolore: un parametro ancora molto inesplorato • La Pain and Discomfort Scale: uno strumento per esplorare la condizione dolorosa nelle persone adulte con disturbo del neurosviluppo • La necessità di protocolli individualizzati

14. Carrefour aero-digestivo nei disturbi dello spettro autistico in breve
Andrea Manzotti

15. Neuroinfiammazione e autismo in breve: dalla ricerca alla pratica clinica
Dario Siniscalco

16. Nuove sfide per una pediatria che cambia. Evoluzione delle conoscenze in ambito eziologico ed epigenetico
Giuseppe Caramia, Maria Vendemmia
I pesticidi organofosforici • Il glifosato: i tre brevetti • Il glifosato: evoluzione delle conoscenze • Project TENDR: Targeting Environmental Neuro-Developmental Risks • Ulteriori evidenze dell’azione dei GBH come interferenti endocrini • Glifosato e disturbi del neurosviluppo • Fattori eziologici ed epigenetici dello spettro autistico

17. Esperienza clinica per una pediatria che cambia
Giuseppe Caramia, Maria Vendemmia
Esami del sangue per eventuali turbe degli elettroliti e vitamine • Considerazioni sulla composizione del microbiota intestinale • Indagini gascromatografiche • Turbe dell’assetto genetico • Inquinamento ambientale • Conclusione

18. Disturbi dello spettro autistico tra traguardi raggiunti e tutele da conquistare
Carlo Cioffi, Maria Vendemmia, Speranza Cioffi
La Giornata mondiale per la consapevolezza dell’autismo • La legislazione italiana relativa agli ASD • Le criticità da affrontare nel prossimo futuro

19. Autismo in età adulta, prima non si sapeva, ora si sa
Mario Diurni, Laura Formenti, Lucio Moderato
Obiettivi • Materiali e metodi • Modello di intervento • Outcomes • Timing • Conclusioni

20. La sfida del XXI secolo: la transizione epidemiologica e i disturbi dello spettro autistico
Salvatore Vendemmia, Maria Vendemmia, Nicola Vendemmia
Malattie croniche non trasmissibili • Strategie d’intervento • Progetto autismo • Misure di prevenzione primaria • Azione sui disturbi dello spettro autistico • Progetto formativo e di ricerca • Obiettivi • Materiali e metodi • Risultati attesi • Conclusioni

Bibliografia

Indice degli autori

Sfoglia

L’indice del libro si può anche sfogliare a questo link.

Parole chiave

autismo • epigenetica • cervello • intestino • microbiota • primi mille giorni • primi 1000 giorni • disturbi dello spettro autistico • Pain and Discomfort Scale • pesticidi • glifosato • GBH interferenti endocrini • gut-immuno-brain-axis • teorie neurocognitive • metabolomica • psicobiotici • connettoma • Clostridia • disbiosi

The post Autismo. Nuove strategie di diagnosi e cura appeared first on Hygeia Press.

How to buy this ebook

Order this book on Amazon!

You can find the ebook “Developmental Nephrology: From Embryology to Metabolomics” in many Amazon stores: amazon.com, amazon.co.uk, amazon.it, amazon.es, amazon.de and amazon.fr. Moreover, you can find this ebook in many other ebookstores (with Italian interface): IBS.it, ultimabooks.it, bookrepublic.it, hoepli.it, sanpaolostore.it, etc.

Description

“Developmental Nephrology: From Embryology to Metabolomics” edited by Vassilios Fanos, Robert L. Chevalier, Gavino Faa, Luigi Cataldi

ISBN 9788890651403, 246 pages, PDF, € 59,99, 1st ebook edition: May 2012

Authors: Rino Agostiniani, Karel Allegaert, Fani Anatolitou, Roberto Antonucci, Jacob V. Aranda, Alessandra Atzei, Luigi Atzori, Luigi Barberini, Kay D. Beharry, Martina Bertin, Luigi Cataldi, Robert L. Chevalier, Nataliya Chorny, Erich Cosmi, Laura Cuzzolin, Ernesto D’Aloja, Mario De Curtis, Angelica Dessì, Gavino Faa, Daniela Fanni, Vassilios Fanos, Gabriele Finco, Helen Georgaki-Angelaki, Clara Gerosa, Hercília Guimarães, Nicoletta Iacovidou, Maria Antonietta Marcialis, Viviana Marinelli, Silvio Maringhini, Alice Melis, Guido Monga, Michele Mussap, Sonia Nemolato, Antonio Noto, Giovanni Ottonello, Maria Dolores Pilloni, Bernadette Pinna, Maria Cristina Pintus, Melania Puddu, Elisabetta Puxeddu, Jacques Rigo, Luigi Ruggeri, Kosmas Sarafidis, Morris Shoeneman, Teresa Tomé, Daniele Trevisanuto, Maria Elisabetta Trudu, Gloria B. Valencia, John N. van den Anker, Silvia Visentin, Murat Yurdakök, Marco Zaffanello, Vincenzo Zanardo

The traditional approach to kidney disorders is changing. In the field of diagnostics much innovative research is ongoing: from the “old” embryology, revisited and re-interpreted with new eyes in the light of immunohistochemistry, up to metabolomics the latest “daughter” of genomics, the most promising and remarkable of the “omics” disciplines.

Between these two extremes we find a universe of novelties, ranging from the most recent urinary biomarkers to the questions of nutrition and growth, as well as those of ethics, which the new populations of extremely low birth weight (ELBW) neonates present to neonatologists and nephrologists.

The studies on perinatal programming expand the temporal horizon of precocious reduction in the number of nephrons, both congenital and/or acquired, thus dilating and multiplying the immediate and long-term negative effects. Neonatal asphyxia, obstructive uropathies, nephrotoxic drugs administered to the mother and/or to the neonate, malnutrition, underfeeding, or overfeeding make it necessary to apply all possible preventive measures to ensure the well-being of the kidney. Because of the kidney’s holistic dimension, the methodical and rigorous study of neonatal nephrology has advanced all aspects of health through the life cycle.

This volume is an update state of the art of the latest discoveries in neonatal and pediatric nephrology. These advances will have an even greater impact when the same children reach adulthood, and the ultimate consequences of perinatal care are unmasked.

Main topics

Aminoglycosides - Antifungals - Aquaporins - Asphyxia - Ethical issues - Intrauterine growth restriction - Italian Neonatal Nephrology Study Group - Kidney embryogenesis - Metabolomics - Nephrotoxicity - Non-steroidal anti-inflammatory drugs - Nutrition - Obstructive uropathy - Pediatric nephrogenic syndrome of inappropriate antidiuresis - Perinatal programming - Pyelonephritis - Sepsis - Ultrasounds - Urinary biomarkers

Contents

1. Kidney embryogenesis: how to look at old things with new eyes
Gavino Faa, Clara Gerosa, Daniela Fanni, Sonia Nemolato, Guido Monga, Vassilios Fanos
A fascinating traffic of cells and tissues • Morphological sequence of events in human kidney development • Molecular regulation of nephrogenesis • Embryology and carcinogenesis: how to better understand kidney tumors by studying tissue expression of transcription factors • Kidney development: can we trace adult kidney behavior to the nine months before birth? • Conclusions and future challenges • References

2. Obstructive uropathy: the state of the art
Robert L. Chevalier
Pathogenesis of obstructive uropathy: animal models • Cellular and molecular mechanisms of obstructive renal injury • Renal growth and glomerular injury • Renal tubular injury • Renal interstitial injury • The role of angiotensin • Evaluation and management of upper tract obstruction • Evaluation and management of lower tract obstruction • Long-term follow-up and the future • References

3. Perinatal programming: long-term consequences for the kidney
Melania Puddu, Luigi Cataldi, Gavino Faa, Murat Yurdakök, Silvio Maringhini, Vassilios Fanos
Is the neonate the father of the adult? • Developmental programming of the kidney and epigenetics • Low neonatal weight and kidney diseases: a dangerous couple • From epidemiology to the clinic and experimentation… • …to pathological anatomy • Renal programming in the VLBW and ELBW: old and new • The influence of pre- and postnatal nutrition • The final number of nephrons as the key factor in the health of the kidney and the organism • Drugs and modulation of nephrogenesis • Future directions • References

4. Aquaporins: implications for the newborn infants
Jacob V. Aranda, Elisabetta Puxeddu, Nataliya Chorny, Morris Shoeneman, Gloria B. Valencia, Kay D. Beharry
Aquaporins • Clinical relevance for the newborn infant •Aquaporins in the eyes • Renal ontogeny of aquaporins • References

5. Pediatric nephrogenic syndrome of inappropriate antidiuresis
Maria Antonietta Marcialis, Angelica Dessì, Maria Cristina Pintus, Bernadette Pinna, Luigi Ruggeri, Vassilios Fanos
Mechanism of action of AVP • Frequency of NSIAD • Symptomatology • Therapy • Future directions • Take-home messages • References

6. Nutrition and kidney in preterm infant
Mario De Curtis, Jacques Rigo
Intrauterine growth and kidney development • Effect of nutrition and growth on the kidney in the postnatal period • Hypercalciuria in preterm infants fed human milk • Maturation of renal function • Renal solute load in preterm infants • Metabolic acidosis and feeding of preterm infants • References

7. Vascular and renal problems among infants with intrauterine growth restriction
Vincenzo Zanardo, Martina Bertin, Vassilios Fanos, Silvia Visentin, Daniele Trevisanuto, Erich Cosmi
The Barker hypothesis and fetal programming of adult disease • Endothelial dysfunction • Fetal programming and renal consequences • Conclusion • References

8. Antenatal non-steroidal anti-inflammatory drugs and the neonatal kidney
Roberto Antonucci, Marco Zaffanello, Maria Dolores Pilloni, Vassilios Fanos
NSAIDs use in pregnancy and the neonatal kidney: general remarks • Placental transfer of NSAIDs • Pathophysiology of COX inhibition • Metabolism and excretion of NSAIDs • Experimental studies in animals • Observational studies in humans • Histopathological findings • Laboratory assessment • Take-home messages • References

9. Renal safety of antifungals and non-steroidal anti-inflammatory drugs in the newborn
Vassilios Fanos, Michele Mussap, Roberto Antonucci, Laura Cuzzolin, Teresa Tomé, Hercília Guimarães
Drug-induced renal damage in the newborn • Physiopathology • Renal safety of antifungals • Renal safety of NSAIDs • References

10. Clinical pharmacology of aminoglycosides and the developing kidney
Karel Allegaert, John N. van den Anker
Aminoglycoside pharmacokinetics: how does the developing kidney handle aminoglycosides? • Aminoglycoside pharmacodynamics: how do aminoglycosides affect the developing kidney? • Clinical relevance • References

11. The kidney in post-asphyctic syndrome: state of the art
Vassilios Fanos, Luigi Atzori, Angelica Dessì, Ernesto D’Aloja, Gabriele Finco, Gavino Faa
How big is the problem? • Physiopathology of postasphyctic kidney damage • Early diagnosis of hypoxic-ischemic kidney damage • Metabolomics in asphyxia • Prediction of acute postasphyctic renal insufficiency • Therapy and prevention • Prognosis • References

12. Renal consequences of perinatal asphyxia: the role of urinary biomarkers
Kosmas Sarafidis
AKI in perinatal asphyxia • Diagnosis of AKI in perinatal asphyxia • Biomarkers of AKI • AKI biomarkers and their potential use in perinatal asphyxia • Conclusions • References

13. Metabolomics in perinatal renal asphyxia
Luigi Atzori, Antonio Noto, Luigi Barberini, Nicoletta Iacovidou, Viviana Marinelli, Vassilios Fanos
The kidneys: the second highest consumers of oxygen after the brain • Perinatal programming theory • Intrauterine growth restriction • Metabolomics • Biological samples in metabolomics • Metabolomics and renal asphyxia • Conclusions • References

14. Biochemical markers in neonatal sepsis-induced acute kidney injury
Michele Mussap, Vassilios Fanos
Neonatal sepsis-induced AKI • Biomarkers for assessing AKI • Biomarkers for assessing systemic inflammation, sepsis, and septic shock • Sepsis-induced AKI biochemical markers • Future prospects • References

15. Ultrasounds and the kidney
Rino Agostiniani
The approach to newborns with suspected urinary tract malformations • Ultrasonography examination of the neonatal urinary tract • The Doppler techniques and the new tools • References

16. Pyelonephritis in the newborn
Giovanni Ottonello, Alessandra Atzei, Angelica Dessì, Maria Elisabetta Trudu, Alice Melis, Vassilios Fanos
Epidemiology/risk factors • Etiology • Clinical medicine • Diagnosis • Therapy • Conclusions • References

17. Ethical issues in the management of neonates with severe renal failure
Fani Anatolitou, Helen Georgaki-Angelaki
Ethical dilemmas • General theoretical basis • Clinical solutions • Quality of life or sanctity of life? • Withholding or withdrawing treatment • Legal aspects • Resource allocation – Socioeconomic factors • Decision-making process • Conclusions • References

18. The Neonatal Nephrology Study Group: 25 years of work
Luigi Cataldi, Gavino Faa, Robert L. Chevalier, Vassilios Fanos; The Italian Society of Neonatology, The Neonatal Nephrology Study Group
Investigations • Teaching Program • Future directions • References

Index

Hardcover

If you prefer to read the physical copy of this book, please click here

The post Developmental Nephrology: From Embryology to Metabolomics (EBOOK) appeared first on Hygeia Press.

How to buy this book

Order this book on Amazon!

Order this book on IBS!

IBS provides international delivery, you can read the delivery rates here: IBS delivery rates.

This book is also available in the bookshops listed on the page “HOW TO ORDER – COME ORDINARE“.

For more information about this book, please send us an email at hygeiapress@hygeiapress.com.

“Developmental Nephrology: From Embryology to Metabolomics” edited by Vassilios Fanos, Robert L. Chevalier, Gavino Faa, Luigi Cataldi

ISBN 9788890438929, book series: Systems Medicine, 272 pages, Hardcover, € 80, 1st edition: October 2011

Authors: Rino Agostiniani, Karel Allegaert, Fani Anatolitou, Roberto Antonucci, Jacob V. Aranda, Alessandra Atzei, Luigi Atzori, Luigi Barberini, Kay D. Beharry, Martina Bertin, Luigi Cataldi, Robert L. Chevalier, Nataliya Chorny, Erich Cosmi, Laura Cuzzolin, Ernesto D’Aloja, Mario De Curtis, Angelica Dessì, Gavino Faa, Daniela Fanni, Vassilios Fanos, Gabriele Finco, Helen Georgaki-Angelaki, Clara Gerosa, Hercília Guimarães, Nicoletta Iacovidou, Maria Antonietta Marcialis, Viviana Marinelli, Silvio Maringhini, Alice Melis, Guido Monga, Michele Mussap, Sonia Nemolato, Antonio Noto, Giovanni Ottonello, Maria Dolores Pilloni, Bernadette Pinna, Maria Cristina Pintus, Melania Puddu, Elisabetta Puxeddu, Jacques Rigo, Luigi Ruggeri, Kosmas Sarafidis, Morris Shoeneman, Teresa Tomé, Daniele Trevisanuto, Maria Elisabetta Trudu, Gloria B. Valencia, John N. van den Anker, Silvia Visentin, Murat Yurdakök, Marco Zaffanello, Vincenzo Zanardo

The traditional approach to kidney disorders is changing. In the field of diagnostics much innovative research is ongoing: from the “old” embryology, revisited and re-interpreted with new eyes in the light of immunohistochemistry, up to metabolomics the latest “daughter” of genomics, the most promising and remarkable of the “omics” disciplines.

Between these two extremes we find a universe of novelties, ranging from the most recent urinary biomarkers to the questions of nutrition and growth, as well as those of ethics, which the new populations of extremely low birth weight (ELBW) neonates present to neonatologists and nephrologists.

The studies on perinatal programming expand the temporal horizon of precocious reduction in the number of nephrons, both congenital and/or acquired, thus dilating and multiplying the immediate and long-term negative effects. Neonatal asphyxia, obstructive uropathies, nephrotoxic drugs administered to the mother and/or to the neonate, malnutrition, underfeeding, or overfeeding make it necessary to apply all possible preventive measures to ensure the well-being of the kidney. Because of the kidney’s holistic dimension, the methodical and rigorous study of neonatal nephrology has advanced all aspects of health through the life cycle.

This volume is an update state of the art of the latest discoveries in neonatal and pediatric nephrology. These advances will have an even greater impact when the same children reach adulthood, and the ultimate consequences of perinatal care are unmasked.

Aminoglycosides – Antifungals – Aquaporins – Asphyxia – Ethical issues – Intrauterine growth restriction – Italian Neonatal Nephrology Study Group – Kidney embryogenesis – Metabolomics – Nephrotoxicity – Non-steroidal anti-inflammatory drugs – Nutrition – Obstructive uropathy – Pediatric nephrogenic syndrome of inappropriate antidiuresis – Perinatal programming – Pyelonephritis – Sepsis – Ultrasounds – Urinary biomarkers

1. Kidney embryogenesis: how to look at old things with new eyes
Gavino Faa, Clara Gerosa, Daniela Fanni, Sonia Nemolato, Guido Monga, Vassilios Fanos
A fascinating traffic of cells and tissues • Morphological sequence of events in human kidney development • Molecular regulation of nephrogenesis • Embryology and carcinogenesis: how to better understand kidney tumors by studying tissue expression of transcription factors • Kidney development: can we trace adult kidney behavior to the nine months before birth? • Conclusions and future challenges • References

2. Obstructive uropathy: the state of the art
Robert L. Chevalier
Pathogenesis of obstructive uropathy: animal models • Cellular and molecular mechanisms of obstructive renal injury • Renal growth and glomerular injury • Renal tubular injury • Renal interstitial injury • The role of angiotensin • Evaluation and management of upper tract obstruction • Evaluation and management of lower tract obstruction • Long-term follow-up and the future • References

3. Perinatal programming: long-term consequences for the kidney
Melania Puddu, Luigi Cataldi, Gavino Faa, Murat Yurdakök, Silvio Maringhini, Vassilios Fanos
Is the neonate the father of the adult? • Developmental programming of the kidney and epigenetics • Low neonatal weight and kidney diseases: a dangerous couple • From epidemiology to the clinic and experimentation… • …to pathological anatomy • Renal programming in the VLBW and ELBW: old and new • The influence of pre- and postnatal nutrition • The final number of nephrons as the key factor in the health of the kidney and the organism • Drugs and modulation of nephrogenesis • Future directions • References

4. Aquaporins: implications for the newborn infants
Jacob V. Aranda, Elisabetta Puxeddu, Nataliya Chorny, Morris Shoeneman, Gloria B. Valencia, Kay D. Beharry
Aquaporins • Clinical relevance for the newborn infant •Aquaporins in the eyes • Renal ontogeny of aquaporins • References

5. Pediatric nephrogenic syndrome of inappropriate antidiuresis
Maria Antonietta Marcialis, Angelica Dessì, Maria Cristina Pintus, Bernadette Pinna, Luigi Ruggeri, Vassilios Fanos
Mechanism of action of AVP • Frequency of NSIAD • Symptomatology • Therapy • Future directions • Take-home messages • References

6. Nutrition and kidney in preterm infant
Mario De Curtis, Jacques Rigo
Intrauterine growth and kidney development • Effect of nutrition and growth on the kidney in the postnatal period • Hypercalciuria in preterm infants fed human milk • Maturation of renal function • Renal solute load in preterm infants • Metabolic acidosis and feeding of preterm infants • References

7. Vascular and renal problems among infants with intrauterine growth restriction
Vincenzo Zanardo, Martina Bertin, Vassilios Fanos, Silvia Visentin, Daniele Trevisanuto, Erich Cosmi
The Barker hypothesis and fetal programming of adult disease • Endothelial dysfunction • Fetal programming and renal consequences • Conclusion • References

8. Antenatal non-steroidal anti-inflammatory drugs and the neonatal kidney
Roberto Antonucci, Marco Zaffanello, Maria Dolores Pilloni, Vassilios Fanos
NSAIDs use in pregnancy and the neonatal kidney: general remarks • Placental transfer of NSAIDs • Pathophysiology of COX inhibition • Metabolism and excretion of NSAIDs • Experimental studies in animals • Observational studies in humans • Histopathological findings • Laboratory assessment • Take-home messages • References

9. Renal safety of antifungals and non-steroidal anti-inflammatory drugs in the newborn
Vassilios Fanos, Michele Mussap, Roberto Antonucci, Laura Cuzzolin, Teresa Tomé, Hercília Guimarães
Drug-induced renal damage in the newborn • Physiopathology • Renal safety of antifungals • Renal safety of NSAIDs • References

10. Clinical pharmacology of aminoglycosides and the developing kidney
Karel Allegaert, John N. van den Anker
Aminoglycoside pharmacokinetics: how does the developing kidney handle aminoglycosides? • Aminoglycoside pharmacodynamics: how do aminoglycosides affect the developing kidney? • Clinical relevance • References

11. The kidney in post-asphyctic syndrome: state of the art
Vassilios Fanos, Luigi Atzori, Angelica Dessì, Ernesto D’Aloja, Gabriele Finco, Gavino Faa
How big is the problem? • Physiopathology of postasphyctic kidney damage • Early diagnosis of hypoxic-ischemic kidney damage • Metabolomics in asphyxia • Prediction of acute postasphyctic renal insufficiency • Therapy and prevention • Prognosis • References

12. Renal consequences of perinatal asphyxia: the role of urinary biomarkers
Kosmas Sarafidis
AKI in perinatal asphyxia • Diagnosis of AKI in perinatal asphyxia • Biomarkers of AKI • AKI biomarkers and their potential use in perinatal asphyxia • Conclusions • References

13. Metabolomics in perinatal renal asphyxia
Luigi Atzori, Antonio Noto, Luigi Barberini, Nicoletta Iacovidou, Viviana Marinelli, Vassilios Fanos
The kidneys: the second highest consumers of oxygen after the brain • Perinatal programming theory • Intrauterine growth restriction • Metabolomics • Biological samples in metabolomics • Metabolomics and renal asphyxia • Conclusions • References

14. Biochemical markers in neonatal sepsis-induced acute kidney injury
Michele Mussap, Vassilios Fanos
Neonatal sepsis-induced AKI • Biomarkers for assessing AKI • Biomarkers for assessing systemic inflammation, sepsis, and septic shock • Sepsis-induced AKI biochemical markers • Future prospects • References

15. Ultrasounds and the kidney
Rino Agostiniani
The approach to newborns with suspected urinary tract malformations • Ultrasonography examination of the neonatal urinary tract • The Doppler techniques and the new tools • References

16. Pyelonephritis in the newborn
Giovanni Ottonello, Alessandra Atzei, Angelica Dessì, Maria Elisabetta Trudu, Alice Melis, Vassilios Fanos
Epidemiology/risk factors • Etiology • Clinical medicine • Diagnosis • Therapy • Conclusions • References

17. Ethical issues in the management of neonates with severe renal failure
Fani Anatolitou, Helen Georgaki-Angelaki
Ethical dilemmas • General theoretical basis • Clinical solutions • Quality of life or sanctity of life? • Withholding or withdrawing treatment • Legal aspects • Resource allocation – Socioeconomic factors • Decision-making process • Conclusions • References

18. The Neonatal Nephrology Study Group: 25 years of work
Luigi Cataldi, Gavino Faa, Robert L. Chevalier, Vassilios Fanos; The Italian Society of Neonatology, The Neonatal Nephrology Study Group
Investigations • Teaching Program • Future directions • References

Index

You can also view the book’s table of contents here: link.

You can download a book flyer here.

If you prefer to read the ebook, please click here

The post Developmental Nephrology: From Embryology to Metabolomics appeared first on Hygeia Press.